Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Memantine in Systemic Lupus Erythematosus [NA]
A clinical trial evaluating memantine for systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Humanized LL2IGG to Treat Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial evaluating a humanized LL2IgG for systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [Phase 1]
A Phase 1 trial evaluating cyclophosphamide and fludarabine for lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
This NIAMS-sponsored clinical trial evaluating antibodies associated with cognitive dysfunction in systemic lupus erythematosus has complete…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
The NIAMS-sponsored clinical trial used positron emission tomography to locate areas of white blood cell activity in systemic lupus erythema…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-02-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Teva Pharmaceuticals USA, Inc. The action represents an …
-
CLINICAL_TRIALS trial_result · 2008-01-14Clinical Trial Update: GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids [Phase 3]
Phase 3 trial evaluating GL701 (Prestara) in women with systemic lupus erythematosus who are receiving glucocorticoids has completed.
-
CLINICAL_TRIALS research · 2008-01-07Clinical Trial Update: To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids [Phase 3]
A Phase 3 clinical trial is evaluating strategies to prevent bone loss in women with systemic lupus erythematosus who are treated with gluco…
-
FDA approval · 2007-12-20FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 trial update assessing the safety and tolerability of MEDI-545 in patients with systemic lupus erythematosus.
-
FDA approval · 2007-09-21FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original ANDA for hydroxychloroquine sulfate, a generic version manufactured by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS research · 2007-09-10Clinical Trial Update: Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity
This clinical trial entry discusses pulse corticosteroid therapy and its effect on brain water diffusivity in patients with Systemic lupus e…
-
CLINICAL_TRIALS trial_result · 2007-06-28Clinical Trial Update: Feasibility and Safety of Acupuncture for Systemic Lupus [NA]
A completed clinical trial from the University of Pittsburgh evaluating the feasibility and safety of acupuncture for systemic lupus erythem…
-
FDA approval · 2007-06-20FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approves a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2007-06-14FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Ipca Laboratories Limited)
FDA approved Ipca Laboratories Limited's original application for hydroxychloroquine sulfate as a generic product.
-
CLINICAL_TRIALS trial_result · 2007-06-07Clinical Trial Update: Effects of Treatment of Chronic Stress in Patients With Lupus [NA]
This clinical trial evaluated the effects of treating chronic stress in patients with systemic lupus erythematosus; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Study of Methotrexate in Lupus Erythematosus [Phase 3]
Phase 3 study of methotrexate in Systemic Lupus Erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: Lupus Atherosclerosis Prevention Study [Phase 4]
The Lupus Atherosclerosis Prevention Study, a Phase 4 clinical trial in systemic lupus erythematosus, has completed. Sponsor: Johns Hopkins …
-
CLINICAL_TRIALS trial_result · 2007-03-20Clinical Trial Update: An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus [Phase 2, Phase 3]
An open-label pilot study of atorvastatin in systemic lupus erythematosus is being conducted in Phase 2 and Phase 3, but the current status …
-
CLINICAL_TRIALS research · 2007-02-14Clinical Trial Update: HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus [NA]
This is a Clinical Trial Update for the HIPP program aimed at helping people with Systemic Lupus Erythematosus; the trial status is unknown …
-
CLINICAL_TRIALS trial_result · 2006-10-25Clinical Trial Update: Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome [Phase 2]
A Phase 2 clinical trial evaluated dehydroepiandrosterone (DHEA) administration in women with systemic lupus erythematosus or primary Sjögre…
-
CLINICAL_TRIALS trial_result · 2006-10-25Clinical Trial Update: Effect of Hormone Replacement Therapy on Lupus Activity [Phase 4]
A Phase 4 clinical trial examining the effect of hormone replacement therapy on disease activity in systemic lupus erythematosus has complet…
-
CLINICAL_TRIALS trial_result · 2006-09-25Clinical Trial Update: Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease [Phase 3]
A Phase 3 trial of abetimus sodium (LJP 394) for lupus nephritis and systemic lupus erythematosus has completed, reporting on safety and eff…